Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Uveitis Treatment Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Anterior Uveitis
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Posterior Uveitis
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Intermediate Uveitis
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Panuveitis
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
Chapter 5 Uveitis Treatment Market by Treatment Type: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Anti-Inflammatory Medications
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Antibiotic/Antiviral Medications
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Immunosuppressive Medications
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
Chapter 6 Uveitis Treatment Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 France
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 Italy
                   6.3.6.1 Market Size and Forecast
          6.3.7 Russia
                   6.3.7.1 Market Size and Forecast
          6.3.8 Others
                   6.3.8.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 South Korea
                   6.4.6.1 Market Size and Forecast
          6.4.7 Others
                   6.4.7.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Novartis AG (ALCON)
    7.2 Valeant Pharmaceutical International Inc.
    7.3 EyeGate Pharmaceuticals Inc.
    7.4 Alimera Sciences Inc.
    7.5 Santen pharmaceutical Co., Ltd.
    7.6 Bausch & Lomb Incorporated.
    7.7 AbbVie Inc.
    7.8 Allergan Inc.
    7.9 Amdipharm Mercury Company Ltd.
    7.10 pSivida Corp.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report